candesartan has been researched along with Arrhythmia in 6 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of low-dose carvedilol combined with candesartan in the prevention of acute and chronic cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer." | 9.17 | [Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer]. ( Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD, 2013) |
| "To investigate the effect of low-dose carvedilol combined with candesartan in the prevention of acute and chronic cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer." | 5.17 | [Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer]. ( Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD, 2013) |
| "Candesartan reduced CTGF expression and attenuated the fibrosis in diabetic rat atria." | 3.77 | Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling. ( Aizawa, T; Fu, LT; Kaneko, S; Kato, T; Sagara, K; Sekiguchi, A; Takamura, M; Tsuneda, T; Yamashita, T, 2011) |
| " We examined whether candesartan, an AT1 receptor blocker, has antiarrhythmic effects on mouse model of left ventricular hypertrophy created by transverse aorta constriction (TAC)." | 3.73 | Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy. ( Horie, M; Kobori, A; Kuwahara, K; Makiyama, T; Yasuno, S; Zankov, DP; Zhang, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Muhailan, M | 1 |
| Al-Shbool, G | 1 |
| Higa, A | 1 |
| Hoshi, H | 1 |
| Yanagisawa, Y | 1 |
| Ito, E | 1 |
| Morisawa, G | 1 |
| Imai, JI | 1 |
| Watanabe, S | 1 |
| Takagi, M | 1 |
| Liu, L | 1 |
| Liu, ZZ | 1 |
| Liu, YY | 1 |
| Zheng, ZD | 1 |
| Liang, XF | 1 |
| Han, YL | 1 |
| Xie, XD | 1 |
| Kato, T | 1 |
| Yamashita, T | 1 |
| Sekiguchi, A | 1 |
| Tsuneda, T | 1 |
| Sagara, K | 1 |
| Takamura, M | 1 |
| Kaneko, S | 1 |
| Aizawa, T | 1 |
| Fu, LT | 1 |
| Zhang, C | 1 |
| Yasuno, S | 1 |
| Kuwahara, K | 1 |
| Zankov, DP | 1 |
| Kobori, A | 1 |
| Makiyama, T | 1 |
| Horie, M | 1 |
| Harada, K | 1 |
| Komuro, I | 1 |
| Hayashi, D | 1 |
| Sugaya, T | 1 |
| Murakami, K | 1 |
| Yazaki, Y | 1 |
1 trial available for candesartan and Arrhythmia
| Article | Year |
|---|---|
[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Co | 2013 |
5 other studies available for candesartan and Arrhythmia
| Article | Year |
|---|---|
Pseudo-Wellens' Syndrome Temporally Associated With Immune Check Point Inhibitors Use.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplast | 2020 |
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Ce | 2017 |
Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Com | 2011 |
Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Com | 2006 |
Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias.
Topics: Angiotensin Receptor Antagonists; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; | 1998 |